{"id":"https://openalex.org/W2153336680","doi":"https://doi.org/10.1007/s13300-013-0030-2","title":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus","display_name":"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus","publication_year":2013,"publication_date":"2013-07-09","ids":{"openalex":"https://openalex.org/W2153336680","doi":"https://doi.org/10.1007/s13300-013-0030-2","mag":"2153336680","pmid":"https://pubmed.ncbi.nlm.nih.gov/23838841","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3889329"},"language":"en","primary_location":{"id":"doi:10.1007/s13300-013-0030-2","doi":"https://doi.org/10.1007/s13300-013-0030-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-013-0030-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0030-2.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6953","issn":["1869-6953","1869-6961"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0030-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065775242","display_name":"Tim Heise","orcid":"https://orcid.org/0000-0002-8346-2037","observed_orcids":["https://orcid.org/0000-0002-8346-2037"]},"institutions":[{"id":"https://openalex.org/I4210165534","display_name":"Profil Institute for Metabolic Research","ror":"https://ror.org/05krxy197","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210165534"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Tim Heise","raw_affiliation_strings":["Profil Institut f\u00fcr Stoffwechselforschung GmbH, Hellersbergstrasse 9, 41460, Neuss, Germany, tim.heise@profil.com","Profil Institut f\u00fcr Stoffwechselforschung GmbH, Hellersbergstrasse 9, 41460, Neuss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Profil Institut f\u00fcr Stoffwechselforschung GmbH, Hellersbergstrasse 9, 41460, Neuss, Germany, tim.heise@profil.com","institution_ids":["https://openalex.org/I4210165534"]},{"raw_affiliation_string":"Profil Institut f\u00fcr Stoffwechselforschung GmbH, Hellersbergstrasse 9, 41460, Neuss, Germany","institution_ids":["https://openalex.org/I4210165534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081810419","display_name":"LEO J. SEMAN","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leo Seman","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06788, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06788, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036322140","display_name":"Sreeraj Macha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210160255","display_name":"Boehringer Ingelheim (United States)","ror":"https://ror.org/05kffp613","country_code":"US","type":"company","lineage":["https://openalex.org/I1330995197","https://openalex.org/I4210160255"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sreeraj Macha","raw_affiliation_strings":["Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06788, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT, 06788, USA","institution_ids":["https://openalex.org/I4210160255"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Peter Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Jones","raw_affiliation_strings":["With Confidence Ltd., Orchard House, Rounce Lane, Woking, Surrey, GU24 9NP, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"With Confidence Ltd., Orchard House, Rounce Lane, Woking, Surrey, GU24 9NP, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032442590","display_name":"Alexandra Marquart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Alexandra Marquart","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077360595","display_name":"Sabine Pinnetti","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sabine Pinnetti","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Str. 65, 88397, Biberach an der Riss, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056064349","display_name":"Hans Juergen Woerle","orcid":"https://orcid.org/0000-0003-2595-1411","observed_orcids":["https://orcid.org/0000-0003-2595-1411"]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hans J. Woerle","raw_affiliation_strings":["Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Str. 173, 55216, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111521277","display_name":"Klaus A. Dugi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330995197","display_name":"Boehringer Ingelheim (Germany)","ror":"https://ror.org/00q32j219","country_code":"DE","type":"company","lineage":["https://openalex.org/I1330995197"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Klaus Dugi","raw_affiliation_strings":["Boehringer Ingelheim GmbH, Binger Str. 173, 55216, Ingelheim am Rhein, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boehringer Ingelheim GmbH, Binger Str. 173, 55216, Ingelheim am Rhein, Germany","institution_ids":["https://openalex.org/I1330995197"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5065775242"],"corresponding_institution_ids":["https://openalex.org/I4210165534"],"apc_list":{"value":7400,"currency":"USD","value_usd":7400},"apc_paid":{"value":7400,"currency":"USD","value_usd":7400},"fwci":10.7719,"has_fulltext":true,"cited_by_count":127,"citation_normalized_percentile":{"value":0.9875327,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"4","issue":"2","first_page":"331","last_page":"345"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/empagliflozin","display_name":"empagliflozin","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9340000152587891},{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9779999852180481},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.921999990940094},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.996999979019165},{"id":"https://openalex.org/keywords/dose-proportionality","display_name":"dose proportionality","score":0.7950000166893005},{"id":"https://openalex.org/keywords/urinary-glucose-excretion","display_name":"urinary glucose excretion","score":0.9359999895095825},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.9179999828338623},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.8289999961853027},{"id":"https://openalex.org/keywords/elimination-half-life","display_name":"elimination half-life","score":0.6449999809265137},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.8309999704360962}],"concepts":[{"id":"https://openalex.org/C2775887513","wikidata":"https://www.wikidata.org/wiki/Q5373824","display_name":"Empagliflozin","level":4,"score":0.9863836765289307},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8455988168716431},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8010457754135132},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7642626762390137},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7429181337356567},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7110223174095154},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5955313444137573},{"id":"https://openalex.org/C2780026642","wikidata":"https://www.wikidata.org/wiki/Q40924","display_name":"Urine","level":2,"score":0.44242194294929504},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.43125972151756287},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.4121879041194916},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4071800708770752},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.391726553440094},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.38916629552841187},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2609577775001526},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1007/s13300-013-0030-2","doi":"https://doi.org/10.1007/s13300-013-0030-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-013-0030-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0030-2.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6953","issn":["1869-6953","1869-6961"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2876920","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3889329","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3889329","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3889329","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Ther","raw_type":"Text"},{"id":"pmid:23838841","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23838841","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes therapy : research, treatment and education of diabetes and related disorders","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s13300-013-0030-2","doi":"https://doi.org/10.1007/s13300-013-0030-2","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13300-013-0030-2","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13300-013-0030-2.pdf","source":{"id":"https://openalex.org/S16535137","display_name":"Diabetes Therapy","issn_l":"1869-6953","issn":["1869-6953","1869-6961"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310246","display_name":"University of Rochester","ror":"https://ror.org/022kthw22"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2153336680.pdf","grobid_xml":"https://content.openalex.org/works/W2153336680.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W172609984","https://openalex.org/W1526927233","https://openalex.org/W1945535054","https://openalex.org/W1997018189","https://openalex.org/W1997746154","https://openalex.org/W1999763887","https://openalex.org/W2027061140","https://openalex.org/W2031815320","https://openalex.org/W2045681644","https://openalex.org/W2059565306","https://openalex.org/W2077519024","https://openalex.org/W2078882023","https://openalex.org/W2095682936","https://openalex.org/W2096733280","https://openalex.org/W2098674879","https://openalex.org/W2111876001","https://openalex.org/W2114276479","https://openalex.org/W2115653936","https://openalex.org/W2122077393","https://openalex.org/W2127833912","https://openalex.org/W2134855422","https://openalex.org/W2149973065","https://openalex.org/W2150855258","https://openalex.org/W2158666727","https://openalex.org/W2169214766","https://openalex.org/W2169403426","https://openalex.org/W2172193326"],"related_works":["https://openalex.org/W1504657738","https://openalex.org/W2128219379","https://openalex.org/W2075224373","https://openalex.org/W1976188658","https://openalex.org/W7099507499","https://openalex.org/W2044904729","https://openalex.org/W2090979363","https://openalex.org/W2524330917","https://openalex.org/W2948056808","https://openalex.org/W1945535054"],"abstract_inverted_index":{"INTRODUCTION:":[0],"This":[1],"study":[2,234],"examined":[3],"the":[4,123,144,232],"safety,":[5],"tolerability,":[6],"pharmacokinetics,":[7],"and":[8,14,70,79,82,102,128,146,203,217,247,271],"pharmacodynamics":[9],"of":[10,34,44,47,131,149,159,163,167,210,264],"empagliflozin,":[11,164],"a":[12,104,160,241],"potent":[13],"highly":[15],"selective":[16],"sodium":[17],"glucose":[18,150,168,196,253,270],"cotransporter":[19],"2":[20,27],"(SGLT2)":[21],"inhibitor,":[22],"in":[23,119,133,152,170,225,244,275],"patients":[24,36,66,276],"with":[25,37,140,182,185,201,206,215,219,257,277],"type":[26],"diabetes":[28],"mellitus":[29],"(T2DM).":[30],"METHODS:":[31],"A":[32],"total":[33,147],"48":[35],"T2DM":[38],"were":[39,85,137,189,222,272],"randomized":[40],"to":[41,115,155,178],"receive":[42],"one":[43],"four":[45],"doses":[46,263],"empagliflozin":[48,202,216,265],"(2.5,":[49],"10,":[50],"25,":[51],"or":[52,56,228],"100":[53],"mg":[54],"qd)":[55],"placebo":[57],"over":[58,172],"8":[59],"days.":[60],"In":[61],"every":[62],"dose":[63,162],"group,":[64],"nine":[65],"received":[67,72],"active":[68],"drug":[69,245],"three":[71],"placebo.":[73,156,186,207,220],"The":[74,107,208],"primary":[75],"endpoint":[76],"was":[77,92,213,255],"safety":[78],"tolerability.":[80],"Pharmacokinetic":[81],"pharmacodynamic":[83],"parameters":[84],"measured":[86],"as":[87],"secondary":[88],"endpoints.":[89],"RESULTS:":[90],"Empagliflozin":[91,142],"rapidly":[93],"absorbed,":[94],"reaching":[95],"peak":[96],"levels":[97,197],"1.5-3.0":[98],"h":[99,174],"after":[100,191],"dosing":[101],"showed":[103],"biphasic":[105],"decline.":[106],"mean":[108],"terminal":[109],"elimination":[110],"half-life":[111],"ranged":[112,175],"from":[113,176],"10":[114],"19":[116],"h.":[117],"Increases":[118],"exposure":[120,246],"(area":[121],"under":[122,231],"plasma":[124,134,195,269],"concentration-time":[125],"curve":[126],"[AUC]":[127],"maximum":[129],"concentration":[130],"analyte":[132],"[C":[135],"max])":[136],"approximately":[138],"proportional":[139],"dose.":[141],"increased":[143],"rate":[145],"amount":[148],"excreted":[151,169],"urine":[153,171,226],"compared":[154,181],"After":[157],"administration":[158],"single":[161],"cumulative":[165],"amounts":[166],"24":[173],"46.3":[177],"89.8":[179],"g,":[180],"5.84":[183],"g":[184],"Similar":[187],"results":[188],"seen":[190],"multiple":[192],"doses.":[193,259],"Fasting":[194],"decreased":[198],"by":[199,204],"17.2-25.8%":[200],"12.7%":[205],"frequency":[209,230],"adverse":[211],"events":[212],"33.3-66.7%":[214],"41.7%":[218],"There":[221],"no":[223],"changes":[224],"volume":[227],"micturition":[229],"controlled":[233],"conditions.":[235],"CONCLUSION:":[236],"Overall,":[237],"pharmacokinetic":[238],"assessments":[239],"demonstrated":[240],"dose-proportional":[242],"increase":[243],"support":[248],"once-daily":[249,261],"dosing.":[250],"Elevated":[251],"urinary":[252],"excretion":[254],"observed":[256],"all":[258],"Multiple":[260],"oral":[262],"(2.5-100":[266],"mg)":[267],"reduced":[268],"well":[273],"tolerated":[274],"T2DM.":[278],"EudraCT":[279],"(2007-000654-32).":[280]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":13},{"year":2014,"cited_by_count":13},{"year":2013,"cited_by_count":3}],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2016-06-24T00:00:00"}